Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

Electrocardiogram - Hypertrophic Cardiomyopathy

Electrocardiogram (ECG or EKG)

An electrocardiogram is one of the simplest and fastest procedures used to evaluate the heart. An EKG records the electrical activity of the heart, shows abnormal rhythms (arrhythmias or dysrhythmias), and detects heart muscle damage. An EKG may be conducted in several ways and used in combination with other tests, such as a stress or exercise test, to evaluate heart function and rhythms.

Learn more about an electrocardiogram (ECG or EKG).

Condition Spotlight

Your Health: Euan Ashley, MD, Discusses Hypertrophic Cardiomyopathy Watch Video

Deadly Heart Condition Yields to Screening and Prompt Treatment Read Story

Hypertrophic Cardiomyopathy Play Video | 59:57

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) Familial Dilated Cardiomyopathy, Heart Failure, Hypertrophic Cardiomyopathy

Exercise in Genetic Cardiovascular Conditions Hypertrophic Cardiomyopathy, Long QT Syndrome,

A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy Cardiomyopathy, Familial Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy

Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure Heart Failure, Hypertrophic Cardiomyopathy

Exercise Study Including Patients With Hypertrophic Cardiomyopathy Hypertrophic Cardiomyopathy,

CY 6031 Study Will Evaluate the Effects of Treatment With Aficamten (CK-3773274) Over a 24-week Period on Cardiopulmonary Exercise Capacity and Health Status in Patients With Symptomatic oHCM Hypertrophic Cardiomyopathy